Jeil Pharma Holdings Inc (KRX:002620)

Jeil Pharma Holdings Revenue

Jeil Pharma Holdings had revenue of 159.78B KRW in the quarter ending June 30, 2025, a decrease of -18.90%. This brings the company's revenue in the last twelve months to 735.79B, down -6.10% year-over-year. In the year 2024, Jeil Pharma Holdings had annual revenue of 779.82B, down -3.01%.

• Revenue (ttm): 735.79B
• Revenue Growth: -6.10%
• P/S Ratio: 0.18
• Revenue / Employee: 19.89B
• Employees: 37
• Market Cap: 135.09B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	779.82B	-24.22B	-3.01%
Dec 31, 2023	804.04B	11.08B	1.40%
Dec 31, 2022	792.96B	30.40B	3.99%
Dec 31, 2021	762.57B	571.30M	0.07%
Dec 31, 2020	762.00B	30.19B	4.13%